Birmingham, AL, United States of America

Shaida Andrabi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Johns Hopkins University. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Shaida Andrabi in Parkinson's Disease Research

Introduction

Shaida Andrabi is an accomplished inventor based in Birmingham, AL (US). She has made significant contributions to the field of neurodegenerative diseases, particularly in the diagnosis and monitoring of Parkinson's disease (PD). Her innovative work focuses on the detection of poly(ADP-ribose) (PAR) in the cerebral spinal fluid (CSF) of patients suffering from PD.

Latest Patents

Shaida Andrabi holds a patent for a novel method that assesses the concentration of PAR in the CSF of patients with Parkinson's disease. This method correlates the PAR concentration to the medical condition of the patient, providing a potential routine laboratory test for diagnosing, assessing, and monitoring PD. The use of PAR as a biomarker for PD is a groundbreaking advancement in the field.

Career Highlights

Shaida Andrabi is affiliated with The Johns Hopkins University, where she continues her research and development in neurodegenerative diseases. Her work has the potential to transform the way Parkinson's disease is diagnosed and monitored, offering hope to many patients.

Collaborations

Shaida has collaborated with notable researchers, including Ted M. Dawson and Valina L. Dawson. These collaborations have further enhanced her research efforts and contributed to the advancement of knowledge in the field of Parkinson's disease.

Conclusion

Shaida Andrabi's innovative approach to detecting PAR in patients with Parkinson's disease represents a significant step forward in medical research. Her contributions have the potential to improve the lives of many individuals affected by this challenging condition.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…